Biovest International Inc (BVTI) Financial Statements (2024 and earlier)

Company Profile

Business Address 324 S HYDE PARK AVE
TAMPA, FL 33606
State of Incorp. DE
Fiscal Year End September 30
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2013
Q1
9/30/2013
Q4
6/30/2013
Q3
3/31/2013
Q2
12/31/2012
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments734312242353
Cash and cash equivalents734312242353
Receivables530464286200
Inventory, net of allowances, customer advances and progress billings329560358402
Inventory329560358402
Prepaid expense and other current assets198169
Costs in excess of billings2401519130
Other undisclosed current assets208456  
Total current assets:2,0411,9431,1751,154
Noncurrent Assets
Property, plant and equipment1,3911,304867900
Intangible assets, net (including goodwill)39,6972,3102,3182,325
Goodwill3,8972,1312,1312,131
Intangible assets, net (excluding goodwill) 35,800179187194
Other noncurrent assets516371 
Prepaid expense and other noncurrent assets557578
Other undisclosed noncurrent assets(21)   
Total noncurrent assets:41,5833,9853,7423,803
TOTAL ASSETS:43,6245,9284,9174,957
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,1001,6318377,049
Accounts payable754787252912
Accrued liabilities3468445856,137
Debt147  29,174
Derivative instruments and hedges, liabilities   155211
Billings in excess of cost 735614
Other undisclosed current liabilities43,0353188,423
Total current liabilities:1,2514,7391,36644,871
Noncurrent Liabilities
Long-term debt and lease obligation391  2,833
Long-term debt, excluding current maturities305  2,833
Capital lease obligations86   
Liabilities, other than long-term debt10264773
Due to related parties    
Other liabilities10264773
Other undisclosed noncurrent liabilities  44,35049,196473
Total noncurrent liabilities:40144,37649,2433,379
Total liabilities:1,65249,11550,60948,250
Equity
Equity, attributable to parent41,972(43,187)(45,692)(43,293)
Common stock1,0001,4651,4651,465
Additional paid in capital42,449131,398131,396131,395
Accumulated deficit(1,477)(176,050)(178,553)(176,153)
Equity, attributable to noncontrolling interest    
Total equity:41,972(43,187)(45,692)(43,293)
TOTAL LIABILITIES AND EQUITY:43,6245,9284,9174,957

Income Statement (P&L) ($ in thousands)

12/31/2013
Q1
9/30/2013
Q4
6/30/2013
Q3
3/31/2013
Q2
12/31/2012
Q1
Revenues(2,559)1,195815549
Revenue, net 1,195815549
Cost of revenue947(788)(578)(581)
Cost of goods and services sold947(788)(578)(1,781)
Gross profit:(1,612)407237(32)
Operating expenses (2,599)(2,176)(1,972)
Other undisclosed operating income4,773788578581
Operating income (loss):3,161(1,404)(1,361)(1,423)
Nonoperating income (expense) 79(798)(1,843)
Investment income, nonoperating  15056645
Interest and debt expense (71)(855)(2,487)
Other undisclosed income from continuing operations before equity method investments, income taxes 2,562718552,487
Income (loss) from continuing operations:5,723(1,325)(2,159)(3,266)
Income (loss) before gain (loss) on sale of properties:5,723(1,325)(2,159)(3,266)
Other undisclosed net income    
Net income (loss):5,723(1,325)(2,159)(3,266)
Net income attributable to noncontrolling interest    
Other undisclosed net income (loss) attributable to parent (3,560)3,828(241) 
Net income (loss) available to common stockholders, diluted:2,1632,503(2,400)(3,266)

Comprehensive Income ($ in thousands)

12/31/2013
Q1
9/30/2013
Q4
6/30/2013
Q3
3/31/2013
Q2
12/31/2012
Q1
Net income (loss):5,723(1,325)(2,159)(3,266)
Comprehensive income (loss):5,723(1,325)(2,159)(3,266)
Comprehensive loss, net of tax, attributable to noncontrolling interest    
Comprehensive income (loss), net of tax, attributable to parent:5,723(1,325)(2,159)(3,266)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: